Nanodiamond Therapeutic Delivery Agents Mediate Enhanced Chemoresistant Tumor Treatment
Top Cited Papers
- 9 March 2011
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 3 (73), 73ra21
- https://doi.org/10.1126/scitranslmed.3001713
Abstract
Nanodiamond-based drug delivery significantly enhanced treatment efficacy and safety in multiple chemoresistant cancer models.This publication has 49 references indexed in Scilit:
- Mesoporous Silica Nanoparticles Facilitate Delivery of siRNA to Shutdown Signaling Pathways in Mammalian CellsSmall, 2010
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature, 2010
- Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growthJCI Insight, 2009
- Drug Delivery with Carbon Nanotubes for In vivo Cancer TreatmentCancer Research, 2008
- PEGylated Nanographene Oxide for Delivery of Water-Insoluble Cancer DrugsJournal of the American Chemical Society, 2008
- Nanometer-Sized Diamond Particle as a Probe for BiolabelingBiophysical Journal, 2007
- Multidrug Transporter ABCG2/Breast Cancer Resistance Protein Secretes Riboflavin (Vitamin B2) into MilkMolecular and Cellular Biology, 2007
- Characterization and application of single fluorescent nanodiamonds as cellular biomarkersProceedings of the National Academy of Sciences, 2007
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005
- MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancerNature, 2004